Tower Research Capital LLC (Trc) Black Diamond Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.29 Billion
  • Q1 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,621 shares of BDTX stock, worth $14,367. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,621
Previous 8,280 20.04%
Holding current value
$14,367
Previous $17,000 41.18%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$1.55 - $2.73 $2,571 - $4,529
-1,659 Reduced 20.04%
6,621 $10,000
Q4 2024

Feb 13, 2025
SELL
$2.14 - $4.17 $8,694 - $16,942
-4,063 Reduced 32.92%
8,280 $17,000
Q3 2024

Nov 14, 2024
BUY
$4.2 - $6.58 $47,472 - $74,373
11,303 Added 1086.83%
12,343 $53,000
Q2 2024

Aug 13, 2024
SELL
$4.65 - $7.39 $19,162 - $30,454
-4,121 Reduced 79.85%
1,040 $4,000
Q1 2024

May 15, 2024
BUY
$2.67 - $5.74 $1,519 - $3,266
569 Added 12.39%
5,161 $26,000
Q4 2023

Feb 13, 2024
SELL
$1.77 - $3.03 $5,766 - $9,871
-3,258 Reduced 41.5%
4,592 $12,000
Q3 2023

Nov 14, 2023
BUY
$2.87 - $4.99 $16,456 - $28,612
5,734 Added 270.98%
7,850 $22,000
Q2 2023

Aug 14, 2023
SELL
$1.43 - $6.18 $7,880 - $34,057
-5,511 Reduced 72.26%
2,116 $10,000
Q1 2023

May 09, 2023
BUY
$1.35 - $3.14 $5,618 - $13,068
4,162 Added 120.12%
7,627 $15,000
Q4 2022

Feb 10, 2023
SELL
$1.27 - $2.51 $1,028 - $2,033
-810 Reduced 18.95%
3,465 $6,000
Q3 2022

Nov 10, 2022
SELL
$1.68 - $4.01 $302 - $721
-180 Reduced 4.04%
4,275 $7,000
Q2 2022

Aug 15, 2022
BUY
$1.5 - $3.63 $1,345 - $3,256
897 Added 25.21%
4,455 $11,000
Q1 2022

May 12, 2022
SELL
$2.66 - $5.61 $20,458 - $43,146
-7,691 Reduced 68.37%
3,558 $10,000
Q4 2021

Feb 14, 2022
BUY
$5.18 - $8.48 $45,817 - $75,005
8,845 Added 367.93%
11,249 $60,000
Q3 2021

Nov 15, 2021
BUY
$8.46 - $12.42 $3,866 - $5,675
457 Added 23.47%
2,404 $20,000
Q2 2021

Aug 16, 2021
BUY
$12.19 - $28.17 $5,643 - $13,042
463 Added 31.2%
1,947 $24,000
Q1 2021

May 17, 2021
SELL
$22.23 - $34.75 $21,229 - $33,186
-955 Reduced 39.16%
1,484 $36,000
Q4 2020

Feb 16, 2021
SELL
$29.47 - $35.0 $344,828 - $409,535
-11,701 Reduced 82.75%
2,439 $78,000
Q3 2020

Nov 16, 2020
BUY
$26.17 - $43.07 $304,723 - $501,507
11,644 Added 466.51%
14,140 $427,000
Q2 2020

Aug 13, 2020
BUY
$22.3 - $44.8 $55,660 - $111,820
2,496 New
2,496 $105,000

Others Institutions Holding BDTX

# of Institutions
94
Shares Held
41.1M
Call Options Held
45.1K
Put Options Held
37K
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $78.9M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email